{"schema_version":"1","generated_at":"2026-10-28T21:02:22.571Z","data_as_of":null,"url":"https://www.findmykol.com/kol/stacie-stapleton","json_url":"https://www.findmykol.com/kol/stacie-stapleton/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"stacie-stapleton","name":"Stacie Stapleton","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"St Petersburg","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1205854692","orcid":"0000-0001-6459-4360","openalex":"A5076875996"},"summary":"Stacie Stapleton is an Oncology physician. OpenAlex indexes 106 publications with 896 citations (h-index 16); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":106,"cited_by_count":896,"h_index":16,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03050450","title":"Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"Johns Hopkins All Children's Hospital","source_url":"https://clinicaltrials.gov/study/NCT03050450","trial_url":"https://www.findmykol.com/trial/NCT03050450"},{"nct":"NCT00876993","title":"Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Johns Hopkins All Children's Hospital","source_url":"https://clinicaltrials.gov/study/NCT00876993","trial_url":"https://www.findmykol.com/trial/NCT00876993"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Day One Biopharmaceuticals","program_year":2025,"amount_usd":1830,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1205854692"},{"payer":"CATALYST PHARMACEUTICALS, INC.","program_year":2025,"amount_usd":105.76,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1205854692"},{"payer":"CATALYST PHARMACEUTICALS, INC.","program_year":2024,"amount_usd":105.18,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1205854692"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1205854692","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Treatment Strategies of Intramedullary Spinal Cord Tumors","year":2026,"journal":"Neurosurgery Clinics of North America","source_url":"https://doi.org/10.1016/j.nec.2026.03.004","status":"verified"},{"title":"Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors","year":2025,"journal":"Neuro-Oncology Practice","source_url":"https://doi.org/10.1093/nop/npaf060","status":"verified"},{"title":"ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.24.01034","status":"verified"},{"title":"A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX, and MYC that promotes group 3 medulloblastoma","year":2024,"journal":"Cell Reports","source_url":"https://doi.org/10.1016/j.celrep.2024.113938","status":"verified"},{"title":"Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis","year":2024,"journal":"Acta Neuropathologica Communications","source_url":"https://doi.org/10.1186/s40478-024-01848-2","status":"verified"}],"source":"works"},"contact":{"address_1":"601 5TH ST S STE 302","city":"St Petersburg","state":"FL","zip":"337014804","phone":"727-767-4176","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1205854692","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-05-09","provider_certified":"2024-05-09","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}